2016
|
Invention
|
Polycyclic lpa1 antagonist and uses thereof.
Described herein is the LPA1 antagonist 1-{4′-[3-me... |
2015
|
Invention
|
Compounds as lysophosphatidic acid receptor antagonists. Described herein are compounds that are ... |
|
Invention
|
Autotaxin inhibitors and uses thereof. Described herein are compounds that are inhibitors of auto... |
2014
|
Invention
|
Polycyclic compounds as lysophosphatidic acid receptor antagonists. Described herein are compound... |
2012
|
Invention
|
Heterocyclic autotaxin inhibitors and uses thereof. Described herein are compounds that are inhib... |
|
Invention
|
Lysophosphatidic acid receptor antagonists. Described herein are compounds that are antagonists o... |
|
Invention
|
3- or 5 - bi phenyl - 4 - ylisoxazole - based compounds useful for the treatment of fibrosis, pai... |
2011
|
Invention
|
Polycyclic lpa1 antagonist and uses thereof. Described herein is the LPA1 antagonist 1-{4′-[3-met... |
|
Invention
|
Polycyclic lpa1 antagonist and uses thereof. Described herein is the LPA1 antagonist 1- {4'-[3-me... |
|
Invention
|
Lysophosphatidic acid receptor antagonists and their use in the treatment fibrosis. Described her... |
|
Invention
|
Lysophosphatidic acid receptor antagonists and uses thereof. Described herein are compounds that ... |
|
Invention
|
Polycyclic antagonists of lysophosphatidic acid receptors. Described herein are compounds that ar... |
|
Invention
|
Lysophosphatidic acid receptor antagonists for the treatment of conditions or diseases of the eye... |
|
Invention
|
Inhalable formulations of lysophosphatidic acid receptor antagonists. Described herein are inhala... |
|
Invention
|
Lysophosphatidic acid receptor antagonist for the treatment of dermal conditions. Described herei... |
|
Invention
|
Lysophosphatidic acid receptor antagonist and uses thereof. Described herein is the LPAl antagoni... |
|
Invention
|
Antagonists of lysophosphatidic acid receptors. Described herein are compounds that are antagonis... |
2010
|
Invention
|
Tricyclic compounds as antagonists of prostaglandin d2 receptors. Described herein are antagonist... |
2009
|
Invention
|
Topical formulations of flap inhibitors for the treatment of dermatological conditions.
Describe... |
|
Invention
|
Topical formulations of flap inhibitors for administration to an eye. Described herein are topica... |
|
Invention
|
Topical formulations of flap inhibitors for the treatment of dermatological conditions. Described... |
|
Invention
|
Antagonists of lysophosphatidic acid receptors.
Described herein are compounds that are antagoni... |
|
Invention
|
Alkyne antagonists of lysophosphatidic acid receptors. Described herein are compounds that are an... |